{iframe}http://www.alzdiscovery.org/wp-content/uploads/2013/05/2013-apoe-rfp_final.pdf{/iframe}
ADDF/Belfer ApoE Therapeutics Innovation Program
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
© 2025 BioHealth Innovation.
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.